Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02906241 · ClinicalTrials.gov registry record · NA
PACCT: Partnering Around Cancer Clinical Trials
A NA study of Prostate Cancer, sponsored by Susan Eggly.
- Completed
- Registry status
- NA
- Development phase
- 316
- Enrollment target
- 2
- Study locations
NCT02906241: Completed NA study of Prostate Cancer, sponsored by Susan Eggly.
NCT02906241 is a NA study of Prostate Cancer that has completed, run by Susan Eggly. The registered enrollment target is 316 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (48% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02906241, a NA study of Prostate Cancer, has completed, sponsored by Susan Eggly.
- COMPLETED
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research has the overall goal of increasing rates at which African American and White men with prostate cancer make an informed decision to participate in a cancer clinical trial.
Primary Outcome
Single item: Did the physician offer a trial?
Conditions Studied
Interventions
- BEHAVIORAL Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams
- BEHAVIORAL Physicians: Educational Module
Study Locations (2)
Maryland
- Johns Hopkins University/Sidney Kimmel Comprehensive Cancer - Baltimore
Michigan
- Karmanos Cancer Institute - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2016-09-20 |
| Est. Completion | 2021-07-17 |
| Phase | NA |
What the finished NCT02906241 record still lists
NCT02906241 is an interventional study that assigns participants to a tested intervention. The registered 316 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams is the first listed.
NCT02906241 reports a single indexed study location in Maryland, Michigan.
Frequently Asked Questions
What is clinical trial NCT02906241 about?
NCT02906241 is a clinical study titled "PACCT: Partnering Around Cancer Clinical Trials". This research has the overall goal of increasing rates at which African American and White men with prostate cancer make an informed decision to participate in a cancer clinical trial.
What is the current status of trial NCT02906241?
This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2016-09-20. Estimated completion is 2021-07-17.
What conditions does trial NCT02906241 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT02906241?
The interventions under investigation include: Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams (BEHAVIORAL), Physicians: Educational Module (BEHAVIORAL).
Who is sponsoring clinical trial NCT02906241?
This trial is sponsored by Susan Eggly, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02906241 being conducted?
This trial has 2 study locations across Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02906241's enrollment target sits among peer trials
316 153rd of 735 higher than 583 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04256317 · 316 participants · Phase 2
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- NCT04787042 · 316 participants · Phase 1
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- NCT04802759 · 316 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- NCT05464056 · 316 participants · NA
BUILT Family Lifestyle Program for Children with ADHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI